Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.
about
Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic targetEpstein-Barr virus infection and posttransplant lymphoproliferative disorderValacyclovir for the treatment of genital herpes.Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumorsPost-transplant lymphoproliferative disorder: case report and review of susceptibility to EBV in the Scottish adult renal transplant pool.Two cases of post transplant lymphoproliferative disorder in lung transplant recipients.Emerging therapies for herpes viral infections (types 1 - 8).Mesothelioma after lung transplantation.Strategies for the prevention of infection after solid organ transplantation.Posttransplant lymphoproliferative disease after lung transplantation.Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.Pediatric lung transplantation: promise being realized.Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.Antiviral Drugs for EBV.
P2860
Q26822550-4F44C96F-D25A-469D-9B95-3A4BEAB8CD0DQ27024229-0E8D7324-81E0-4E89-AFBE-BA0EFEE7024FQ34568338-1071EB7A-F389-41D1-AAD0-CF9480696245Q34767204-3AEC98B1-A1D5-4385-AF14-EDB1AD0E2B70Q35574186-EBEBB8AA-7A48-4876-B285-C3B398B8B954Q35936913-45FC10E3-7D24-4F46-8E22-29ADA0026488Q35967376-108A7638-7824-428D-895C-BDF895109643Q36184293-80676AAE-A0CE-4B4C-9CA7-1F63B816B461Q36670902-D458FAE7-9035-456F-8C00-D95C939E8B78Q36701511-B3D6BFD1-C4A2-4C79-892F-CB6A68FB4551Q37824825-2067C733-A950-46C0-B9B5-BE0D8EC1EF38Q38204614-B49A6764-52A8-4319-9A4A-5488F0CB63B9Q38470211-4ED8B9C1-ED88-41A5-A3FB-6B1A20E432A7Q38933152-F8EA4AB7-6805-4072-9889-B74A38CC98EBQ39887714-CCCD60E4-D74B-4C16-AAE2-F2E9EB68EAEBQ40255111-1E1D635A-17EC-45B9-B84A-C2F4AF7FBE6AQ42109765-542E2AA2-ADF8-4F06-B1E5-F398A79A4762Q45358050-2C80F98A-A20F-4F08-9B31-FE1B25922B40Q47604346-72E038E0-B4DD-4D3E-A57C-BA634095F215Q55461330-E9416F6F-BAB5-4627-87C8-0EF319DBE1B0
P2860
Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Anti-viral prophylaxis reduces ...... in lung transplant recipients.
@en
Anti-viral prophylaxis reduces ...... in lung transplant recipients.
@nl
type
label
Anti-viral prophylaxis reduces ...... in lung transplant recipients.
@en
Anti-viral prophylaxis reduces ...... in lung transplant recipients.
@nl
prefLabel
Anti-viral prophylaxis reduces ...... in lung transplant recipients.
@en
Anti-viral prophylaxis reduces ...... in lung transplant recipients.
@nl
P2093
P1476
Anti-viral prophylaxis reduces ...... in lung transplant recipients
@en
P2093
Allan R Glanville
Marshall Plit
Monique A Malouf
Peter Hopkins
Prashant N Chhajed
P304
P356
10.1016/S1053-2498(01)00407-7
P577
2002-05-01T00:00:00Z